GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » EV-to-EBIT

CurveBeam AI (ASX:CVB) EV-to-EBIT : -4.46 (As of May. 31, 2024)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CurveBeam AI's Enterprise Value is A$57.19 Mil. CurveBeam AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-12.83 Mil. Therefore, CurveBeam AI's EV-to-EBIT for today is -4.46.

The historical rank and industry rank for CurveBeam AI's EV-to-EBIT or its related term are showing as below:

ASX:CVB' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.46   Med: -0.62   Max: -0.42
Current: -4.46

During the past 3 years, the highest EV-to-EBIT of CurveBeam AI was -0.42. The lowest was -4.46. And the median was -0.62.

ASX:CVB's EV-to-EBIT is ranked worse than
100% of 449 companies
in the Medical Devices & Instruments industry
Industry Median: 19.76 vs ASX:CVB: -4.46

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. CurveBeam AI's Enterprise Value for the quarter that ended in Dec. 2023 was A$131.45 Mil. CurveBeam AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-12.83 Mil. CurveBeam AI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -9.76%.


CurveBeam AI EV-to-EBIT Historical Data

The historical data trend for CurveBeam AI's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI EV-to-EBIT Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
EV-to-EBIT
- - -

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
EV-to-EBIT - - - - -

Competitive Comparison of CurveBeam AI's EV-to-EBIT

For the Medical Devices subindustry, CurveBeam AI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CurveBeam AI's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's EV-to-EBIT falls into.



CurveBeam AI EV-to-EBIT Calculation

CurveBeam AI's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=57.194/-12.834
=-4.46

CurveBeam AI's current Enterprise Value is A$57.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-12.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI  (ASX:CVB) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CurveBeam AI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-12.834/131.44521
=-9.76 %

CurveBeam AI's Enterprise Value for the quarter that ended in Dec. 2023 was A$131.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-12.83 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines